These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 21366533

  • 1. Shikimate kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: kinetics and structural dynamics of a potential molecular target for drug development.
    Saidemberg DM, Passarelli AW, Rodrigues AV, Basso LA, Santos DS, Palma MS.
    Curr Med Chem; 2011; 18(9):1299-310. PubMed ID: 21366533
    [Abstract] [Full Text] [Related]

  • 2. Crystal structure of shikimate kinase from Mycobacterium tuberculosis reveals the dynamic role of the LID domain in catalysis.
    Gu Y, Reshetnikova L, Li Y, Wu Y, Yan H, Singh S, Ji X.
    J Mol Biol; 2002 Jun 07; 319(3):779-89. PubMed ID: 12054870
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid.
    Pereira JH, de Oliveira JS, Canduri F, Dias MV, Palma MS, Basso LA, Santos DS, de Azevedo WF.
    Acta Crystallogr D Biol Crystallogr; 2004 Dec 07; 60(Pt 12 Pt 2):2310-9. PubMed ID: 15583379
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development of an ESI-LC-MS-based assay for kinetic evaluation of Mycobacterium tuberculosis shikimate kinase activity and inhibition.
    Simithy J, Gill G, Wang Y, Goodwin DC, Calderón AI.
    Anal Chem; 2015 Feb 17; 87(4):2129-36. PubMed ID: 25629762
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis.
    Kumar M, Verma S, Sharma S, Srinivasan A, Singh TP, Kaur P.
    Chem Biol Drug Des; 2010 Sep 01; 76(3):277-84. PubMed ID: 20626408
    [Abstract] [Full Text] [Related]

  • 10. Mycobacterium tuberculosis shikimate kinase inhibitors: design and simulation studies of the catalytic turnover.
    Blanco B, Prado V, Lence E, Otero JM, Garcia-Doval C, van Raaij MJ, Llamas-Saiz AL, Lamb H, Hawkins AR, González-Bello C.
    J Am Chem Soc; 2013 Aug 21; 135(33):12366-76. PubMed ID: 23889343
    [Abstract] [Full Text] [Related]

  • 11. Shikimate kinase: a potential target for development of novel antitubercular agents.
    Pereira JH, Vasconcelos IB, Oliveira JS, Caceres RA, de Azevedo WF, Basso LA, Santos DS.
    Curr Drug Targets; 2007 Mar 21; 8(3):459-68. PubMed ID: 17348838
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of phosphoryl transfer catalyzed by shikimate kinase from Mycobacterium tuberculosis.
    Hartmann MD, Bourenkov GP, Oberschall A, Strizhov N, Bartunik HD.
    J Mol Biol; 2006 Dec 01; 364(3):411-23. PubMed ID: 17020768
    [Abstract] [Full Text] [Related]

  • 13. Crystal structure of Mycobacterium tuberculosis shikimate kinase in complex with shikimic acid and an ATP analogue.
    Gan J, Gu Y, Li Y, Yan H, Ji X.
    Biochemistry; 2006 Jul 18; 45(28):8539-45. PubMed ID: 16834327
    [Abstract] [Full Text] [Related]

  • 14. Crystallographic studies of shikimate binding and induced conformational changes in Mycobacterium tuberculosis shikimate kinase.
    Dhaliwal B, Nichols CE, Ren J, Lockyer M, Charles I, Hawkins AR, Stammers DK.
    FEBS Lett; 2004 Sep 10; 574(1-3):49-54. PubMed ID: 15358538
    [Abstract] [Full Text] [Related]

  • 15. Molecular model of shikimate kinase from Mycobacterium tuberculosis.
    Filgueira de Azevedo W, Canduri F, Simões de Oliveira J, Basso LA, Palma MS, Pereira JH, Santos DS.
    Biochem Biophys Res Commun; 2002 Jul 05; 295(1):142-8. PubMed ID: 12083781
    [Abstract] [Full Text] [Related]

  • 16. Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis.
    Rajput VS, Mehra R, Kumar S, Nargotra A, Singh PP, Khan IA.
    Appl Microbiol Biotechnol; 2016 Jun 05; 100(12):5415-26. PubMed ID: 26887318
    [Abstract] [Full Text] [Related]

  • 17. Dynamics of glyphosate-induced conformational changes of Mycobacterium tuberculosis 5-enolpyruvylshikimate-3-phosphate synthase (EC 2.5.1.19) determined by hydrogen-deuterium exchange and electrospray mass spectrometry.
    Marques MR, Vaso A, Neto JR, Fossey MA, Oliveira JS, Basso LA, dos Santos DS, de Azevedo Junior WF, Palma MS.
    Biochemistry; 2008 Jul 15; 47(28):7509-22. PubMed ID: 18558720
    [Abstract] [Full Text] [Related]

  • 18. Structures of Helicobacter pylori shikimate kinase reveal a selective inhibitor-induced-fit mechanism.
    Cheng WC, Chen YF, Wang HJ, Hsu KC, Lin SC, Chen TJ, Yang JM, Wang WC.
    PLoS One; 2012 Jul 15; 7(3):e33481. PubMed ID: 22438938
    [Abstract] [Full Text] [Related]

  • 19. Interaction of shikimic acid with shikimate kinase.
    Pereira JH, de Oliveira JS, Canduri F, Dias MV, Palma MS, Basso LA, de Azevedo WF, Santos DS.
    Biochem Biophys Res Commun; 2004 Dec 03; 325(1):10-7. PubMed ID: 15522194
    [Abstract] [Full Text] [Related]

  • 20. Freezing the Dynamic Gap for Selectivity: Motion-Based Design of Inhibitors of the Shikimate Kinase Enzyme.
    Prado V, Lence E, Thompson P, Hawkins AR, González-Bello C.
    Chemistry; 2016 Dec 12; 22(50):17988-18000. PubMed ID: 27699905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.